-
The first HFMD vaccine in China will enter the field for inspection and is expected to be approved within this year
Time of Update: 2020-04-03
In addition to the Institute of medical biology, Chinese Academy of Medical Sciences, science and Technology (NASDAQ: SVA) and Wuhan Institute of Biological Products Co., Ltd. have also applied for the production approval documents of the vaccine.
-
China's EV71 inactivated vaccine against HFMD has entered the final stage of evaluation
Time of Update: 2020-04-03
Wang Lifeng, director of CFDA pharmaceutical and chemical department, introduced at a press conference on the morning of July 4 that the clinical trials of EV71 inactivated (Vero
-
Also has the whole body to use the antibacterials to have the appraisal! This billion yuan product has reached 8
Time of Update: 2020-02-16
According to the data of minenet, the terminal sales of Cefalexin in China's public medical institutions reached 265 million yuan in 2018.
-
Novel coronavirus infection supporting the epidemic prevention and control policy on personal income tax announcement
Time of Update: 2020-02-07
The Ministry of Finance and the State Administration of Taxation jointly issued an announcement to clarify that the temporary work subsidies and bonuses obtained by medical
-
Wuhan insulin price negotiation opened, and representatives of pharmaceutical companies wept on the spot
Time of Update: 2020-01-10
[industry trends of pharmaceutical network] on January 9, Wuhan took the lead in launching negotiation on purchasing insulin with quantity
According to the on-site video
-
The latest announcement: the punishment regulations for designated drugstores are coming
Time of Update: 2020-01-06
Source: Jiangsu Medical Insurance Bureau Sorting out: saibelan - drugstore Manager The latest version of the supervision and management plan for designated drugstores has been
-
Report of Wuhan health and Health Committee: many cases of pneumonia found were viral pneumonia
Time of Update: 2020-01-02
According to the report of Wuhan Health Committee, Wuhan city organized the consultation of clinical medicine, epidemiology and virology experts from Tongji Hospital, provincial CDC, Wuhan Institute of Virology, Wuhan infectious disease hospital, Wuhan CDC and other units.
-
What are the protection measures for the short-term shutdown of medical purified water equipment
Time of Update: 2019-12-31
Therefore, I suggest that when the water temperature of medical purified water equipment is higher than 20 ℃, we use low-pressure flushing every 2D or 1D.
-
Cut the price by 85%! International machinery enterprises such as belang, Telford and Yuyue were undercut
Time of Update: 2019-12-20
Big price reduction of consumables at the end of the year
According to the official wechat of Zhenjiang Medical Insurance Center, on December 17, a four city alliance
-
How to judge the breakdown of reverse osmosis membrane in medical purified water equipment
Time of Update: 2019-12-19
There are many reasons for the failure of medical purified water equipment, which need to be analyzed, checked and solved.
-
Hundred billion "chronic disease market" is very attractive, Yangtze River, East China Medicine Show your powers and speed up the layout
Time of Update: 2019-12-06
In fact, the layout of chronic disease drug market of pharmaceutical enterprises can also be seen from the consistency evaluation.
-
Current situation of chronic disease management at home and abroad and exploration of MTM model
Time of Update: 2019-11-25
The purpose of this paper is to explore the feasibility of MTM services in China by understanding the current situation and management of chronic diseases in China and the United States.
-
Weigh! The CPPCC National Committee held a meeting to solve the treatment of village doctors
Time of Update: 2019-11-13
Source: cppcc.com Organized by: Liu Xiaolin, a community of grassroots doctors The CPPCC National Committee held a symposium to propose new solutions to the problems of village doctors' resignation, low wages at the grassroots level, and difficulty in promotion.
-
"Start early and catch up late" DRG payment standard is officially unified
Time of Update: 2019-11-12
On October 23, the State Medical Security Bureau issued the notice on printing and distributing the technical specifications and grouping schemes for DRG paid national pilot
-
Jingfeng pharmaceutical lost 140 million in the first three quarters, down 200% year on year
Time of Update: 2019-10-30
On October 28, Jingfeng pharmaceutical released the third quarter quarterly report, and the overall operating revenue declined seriously, which was not optimistic
Since
-
How to set the penalty amount for a large number of machinery enterprises
Time of Update: 2019-10-23
Similarly, a traditional Chinese medicine clinic in Sanya was confiscated 1120 acupuncture needles and fined 25000 yuan by Sanya market supervision administration due to the use of expired medical devices.
-
60 billion high blood pressure diabetes drugs, welcome medical insurance outpatient "double channel" good, which drugs profit
Time of Update: 2019-10-15
Finally, the volume of low value consumables procurement, also came
From 10 yuan to 3 yuan, on August 20, Nanjing Medical Insurance Bureau released the announcement
-
SDA formally joined imdrf national regulatory agency report information exchange mechanism
Time of Update: 2019-09-20
On September 19, at the 16th Management Committee meeting of the international medical device regulatory Forum (imdrf) held in Yekaterinburg, Russia, the Chinese delegation applied
-
Nanjing implements credit classified supervision in the field of medical and health care
Time of Update: 2019-09-18
In principle, the "Red List" of medical and health trustworthy shall be generated from the "a" of honesty and trustworthiness, and shall be managed in accordance with the relevant provisions of the "Red List" of national medical and health trustworthy.
-
The R & D cost is about 7.3 million yuan, and Kelun pharmaceutical is the first to pass the consistency evaluation
Time of Update: 2019-04-11
Up to now, according to the announcement, Kelun pharmaceutical has invested about 7.3 million yuan in the consistency evaluation project of Cefalexin Capsules.
